Return on Equity (ROE)
Updated 80h ago
Sector Performance
60th percentileBKR
17.2%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how much profit a company generates from each dollar of shareholders' equity; BKR's current ROE of 17.2% means it earns $0.172 for every $1 of equity.
This is above the sector median of 13.7%, placing BKR in the 60th percentile among its sector peers, indicating above-average profitability relative to competitors. No year-over-year or quarter-over-quarter change is available, so there is no trend data to assess direction over the last eight quarters. The combination of a high current ROE with no trend information suggests the investment risk depends on whether this level can be sustained, but without historical context, the opportunity is unclear. This metric supports the overall NEUTRAL verdict because the ROE is solidly above the sector median, yet the absence of trend data prevents drawing a stronger bullish or bearish conclusion.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about BKR?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are BKR's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master BKR's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full BKR research report →BKR
17.2%
Sector Median
13.8%
Sector Avg
31.4%
How BKR's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.